This antibody that recognizes the cancer-associated antigen OSM-R.beta can inhibit the growth of renal cancer and ovarian cancer cell lines in a dose dependent manner.
Figure 1 The graphed results of several experiments illustrating the in vitro inhibition of a human renal carcinoma cell line grown in a monolayer by an anti-OSM-R.beta antibody.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-0869CL-S(P) | Anti-Human OSM-R.beta Recombinant Antibody scFv Fragment (LUCA38) | FC, ICC | |
TAB-0869CL-F(E) | Anti-Human OSM-R.beta Recombinant Antibody Fab Fragment (LUCA38) | FC, ICC |
There are currently no Customer reviews or questions for TAB-0869CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.